All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

GlaxoSmithKline plc revenue reports

GlaxoSmithKline plc financial reports, GlaxoSmithKline plc annual revenue in 2024. When does GlaxoSmithKline plc report revenue?
Add to widgets
Added to widgets

GlaxoSmithKline plc total revenue, net income and dynamics of changes in Euro today

GlaxoSmithKline plc net revenue for today is 8 092 000 000 €. The dynamics of net income of GlaxoSmithKline plc has changed by 322 000 000 € in recent years. Here are the main financial indicators of GlaxoSmithKline plc. Chart of online financial report of GlaxoSmithKline plc. The financial report chart shows the values from 31/03/2019 to 30/06/2021. GlaxoSmithKline plc financial report on the graph shows the dynamics of assets.

Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
30/06/2021 7 565 089 420 € +3.62 % ↑ 1 304 164 575 € +44.71 % ↑
31/03/2021 6 934 976 930 € -3.172 % ↓ 1 003 131 605 € +29.28 % ↑
31/12/2020 8 169 960 015 € -1.798 % ↓ 632 917 145 € -47.883 % ↓
30/09/2020 8 083 015 710 € -7.874 % ↓ 1 162 996 940 € -19.845 % ↓
31/12/2019 8 319 541 615 € - 1 214 415 615 € -
30/09/2019 8 773 895 725 € - 1 450 941 520 € -
30/06/2019 7 300 516 965 € - 901 229 140 € -
31/03/2019 7 162 153 985 € - 775 954 550 € -
Show:
to

GlaxoSmithKline plc financial report charts

The latest dates of GlaxoSmithKline plc financial statements available online: 31/03/2019, 31/03/2021, 30/06/2021. The dates of the financial statements are determined by the accounting rules. The latest financial report of GlaxoSmithKline plc is available online for such a date - 30/06/2021. Gross profit GlaxoSmithKline plc is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit GlaxoSmithKline plc is 5 573 000 000 €

GlaxoSmithKline plc quarterly report dates

Cost of revenue GlaxoSmithKline plc is the total cost of producing and distributing of products and services of a company. Cost of revenue GlaxoSmithKline plc is 2 519 000 000 € Total revenue GlaxoSmithKline plc refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue GlaxoSmithKline plc is 8 092 000 000 € Operating income GlaxoSmithKline plc is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income GlaxoSmithKline plc is 1 979 000 000 €

Net income GlaxoSmithKline plc is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income GlaxoSmithKline plc is 1 395 000 000 € Current assets GlaxoSmithKline plc is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets GlaxoSmithKline plc is 17 566 000 000 € Total assets GlaxoSmithKline plc refers to the total amount of assets owned by a person or entity. Total assets GlaxoSmithKline plc is 77 011 000 000 €

30/06/2021 31/03/2021 31/12/2020 30/09/2020 31/12/2019 30/09/2019 30/06/2019 31/03/2019
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
5 210 114 105 € 4 655 727 300 € 5 400 830 645 € 5 541 998 280 € 5 508 342 420 € 5 991 677 965 € 5 027 811 530 € 4 942 736 995 €
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
2 354 975 315 € 2 279 249 630 € 2 769 129 370 € 2 541 017 430 € 2 811 199 195 € 2 782 217 760 € 2 272 705 435 € 2 219 416 990 €
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
7 565 089 420 € 6 934 976 930 € 8 169 960 015 € 8 083 015 710 € 8 319 541 615 € 8 773 895 725 € 7 300 516 965 € 7 162 153 985 €
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
- - - - - - - -
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
1 850 137 415 € 1 504 229 965 € 1 861 356 035 € 2 297 947 330 € 2 031 505 105 € 2 397 045 140 € 1 793 109 430 € 1 824 895 520 €
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
1 304 164 575 € 1 003 131 605 € 632 917 145 € 1 162 996 940 € 1 214 415 615 € 1 450 941 520 € 901 229 140 € 775 954 550 €
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
1 112 513 150 € 1 031 178 155 € 1 235 917 970 € 996 587 410 € 1 104 099 185 € 1 100 359 645 € 989 108 330 € 924 601 265 €
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
5 714 952 005 € 5 430 746 965 € 6 308 603 980 € 5 785 068 380 € 6 288 036 510 € 6 376 850 585 € 5 507 407 535 € 5 337 258 465 €
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
16 422 189 910 € 17 317 809 740 € 18 928 616 595 € 18 586 448 685 € 18 221 843 535 € 19 623 236 150 € 17 041 083 780 € 16 382 924 740 €
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
71 996 428 735 € 72 994 885 915 € 75 193 735 435 € 75 657 438 395 € 74 502 855 420 € 77 824 501 825 € 59 488 602 320 € 58 304 103 025 €
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
3 274 902 155 € 4 447 247 945 € 5 882 296 420 € 4 004 112 455 € 4 400 503 695 € 4 024 679 925 € 3 854 530 855 € 3 862 944 820 €
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
- - - - 22 483 984 250 € 23 852 655 890 € 24 100 400 415 € 22 867 287 100 €
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
- - - - - - - -
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
- - - - 57 341 171 475 € 60 940 478 725 € 56 714 798 525 € 55 152 605 690 €
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
- - - - 76.97 % 78.31 % 95.34 % 94.59 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
14 375 726 645 € 13 897 065 525 € 13 637 167 495 € 13 355 767 110 € 10 662 363 425 € 11 005 466 220 € 3 378 674 390 € 3 752 628 390 €
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
- - - - 3 228 157 905 € 2 351 235 775 € 1 298 555 265 € 619 828 755 €

Last revenue report of GlaxoSmithKline plc was 30/06/2021. According to last financial report total revenue in GlaxoSmithKline plc was 7 565 089 420 Euro and changed by +3.62% since last year. Net income in GlaxoSmithKline plc was 1 304 164 575 € in last quartal, net income changes to +44.71%.

Current cash GlaxoSmithKline plc - the sum of all of the cash a company has on the date of report. Current cash GlaxoSmithKline plc is 3 503 000 000 €

GlaxoSmithKline plc stocks data

GlaxoSmithKline plc financials